Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis
- 7 August 2009
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 214 (1-2), 67-77
- https://doi.org/10.1016/j.jneuroim.2009.06.023
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- IL-17 Plays an Important Role in the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2006
- Treatment with an Estrogen Receptor Ligand Is Neuroprotective in Experimental Autoimmune EncephalomyelitisJournal of Neuroscience, 2006
- Virtual and biomolecular screening converge on a selective agonist for GPR30Nature Chemical Biology, 2006
- Statistical analysis of data from studies on experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2005
- Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated miceJournal of Neuroimmunology, 2005
- Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signalingBritish Journal of Pharmacology, 2005
- Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligandsJournal of Endocrinology, 2005
- A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell SignalingScience, 2005
- Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer CellsEndocrinology, 2005
- Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1Journal of Neuroimmunology, 1998